Drug Description in Trials / DrugBank / KEGG DRUG

Search results

descriptions per page:

Showing 1 to 10 of 10 descriptions

Filter by

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	(1-3)-beta-D-Glucan (BDG) assay (Fungitell)	-	-	-	-	[1] 107
2	(1-3)-ß-D-Glucan (BDG) assay (Fungitell)	-	-	-	-	[1] 107
3	BD	-	-	-	-	[2] 28, 56
4	BDMARD	-	-	-	-	[1] 46
5	BDMARD treatment	-	-	-	-	[1] 271
6	BDMARD withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatace ...	[5] Abatacept, Adalimumab, Etanercept, Golimumab, Infliximab	[5] D00742 , D02597 , D02598 , D03203 , D04358	[4] CD80, CD86, LTA, TNF 💬	[74] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African ...	[1] 46
7	Biological disease-modifying antirheumatic drugs (bDMARDs)	-	-	-	-	[1] 46
8	Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone	[2] Bortezomib, Dexamethasone	[2] D00292 , D03150	[2] NR3C1, PSMB5 💬	[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ...	[1] 28
9	Cannabidiol Botanical Drug Substance (CBD BDS)	[1] Cannabidiol	[1] D10915	[2] CNR1, CNR2 💬	[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid sign ...	[1] 13
10	TETRAHYDROCANNABINOL Botanical Drug Substance (THC BDS)	[1] Dronabinol	[1] D00306	[2] CNR1, CNR2 💬	[4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid sign ...	[1] 13

First Previous1Next Last